Insiders · Profile

BRISTOW MICHAEL R

Pres. & Chief Executive Offic at Oruka Therapeutics. Filing since 25 Jan 2013. CIK 0001266125

Company
Date
Role
Action
Shares
Amount
Of holding
4 Apr 2017
Pres. & Chief Executive Offic
Sold, plan not stated
720
$1.74K
1.7%
28 Feb 2017
Pres. & Chief Executive Offic
Sold, plan not stated
763
$1.99K
1.8%
20 Sep 2016
Pres. & Chief Executive Offic
Sold, plan not stated
1,972
$5.70K
4.4%
5 Apr 2016
See Remarks
Sold, plan not stated
724
$2.55K
1.6%
1 Mar 2016
See Remarks
Sold, plan not stated
752
$2.63K
1.6%
18 Sep 2015
See Remarks
Sold, plan not stated
1,809
$11.45K
3.8%
2 Mar 2015
See Remarks
Sold, plan not stated
5,446
$3.88K
1.6%
18 Sep 2014
President and CEO
Sold, plan not stated
13,853
$18.01K
4.5%
25 Jan 2013
President and CEO
Bought
1,069,290
$500.00K
opened
9 decisions on file.